These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 1723342

  • 41. Production of interleukin-1 by microglia in response to substance P: role for a non-classical NK-1 receptor.
    Martin FC, Anton PA, Gornbein JA, Shanahan F, Merrill JE.
    J Neuroimmunol; 1993 Jan; 42(1):53-60. PubMed ID: 7678597
    [Abstract] [Full Text] [Related]

  • 42. Apparent molecular weight of substance P/neurokinin-1 receptors determined using a photoaffinity labelled probe, [(3'-125I) D-Tyro, (4'-N3)Phe8, Nle11]-substance P.
    Dam TV, Escher E, Quirion R.
    Biochem Biophys Res Commun; 1987 Nov 30; 149(1):297-303. PubMed ID: 2446621
    [Abstract] [Full Text] [Related]

  • 43. Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist.
    Gitter BD, Bruns RF, Howbert JJ, Waters DC, Threlkeld PG, Cox LM, Nixon JA, Lobb KL, Mason NR, Stengel PW.
    J Pharmacol Exp Ther; 1995 Nov 30; 275(2):737-44. PubMed ID: 7473161
    [Abstract] [Full Text] [Related]

  • 44. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P.
    Pradier L, Ménager J, Le Guern J, Bock MD, Heuillet E, Fardin V, Garret C, Doble A, Mayaux JF.
    Mol Pharmacol; 1994 Feb 30; 45(2):287-93. PubMed ID: 7509440
    [Abstract] [Full Text] [Related]

  • 45. Epidermal growth factor differentially regulates low density lipoprotein receptor-related protein gene expression in neoplastic and fetal human astrocytes.
    Hussaini IM, Brown MD, Karns LR, Carpenter J, Redpath GT, Gonias SL, Vandenberg SR.
    Glia; 1999 Jan 30; 25(1):71-84. PubMed ID: 9888299
    [Abstract] [Full Text] [Related]

  • 46. Specific down-regulation of parathyroid hormone (PTH) receptors and responses to PTH by tumour necrosis factor alpha and retinoic acid in UMR 106-06 osteoblast-like osteosarcoma cells.
    Schneider HG, Allan EH, Moseley JM, Martin TJ, Findlay DM.
    Biochem J; 1991 Dec 01; 280 ( Pt 2)(Pt 2):451-7. PubMed ID: 1660713
    [Abstract] [Full Text] [Related]

  • 47. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Veerhuis R, Janssen I, De Groot CJ, Van Muiswinkel FL, Hack CE, Eikelenboom P.
    Exp Neurol; 1999 Nov 01; 160(1):289-99. PubMed ID: 10630213
    [Abstract] [Full Text] [Related]

  • 48. Characteristics of the binding of [3H]-mepyramine to intact human U373 MG astrocytoma cells: evidence for histamine-induced H1-receptor internalisation.
    Hishinuma S, Young JM.
    Br J Pharmacol; 1995 Nov 01; 116(6):2715-23. PubMed ID: 8590995
    [Abstract] [Full Text] [Related]

  • 49. Substance P regulation of glutamate and cystine transport in human astrocytoma cells.
    Johnson CL, Johnson CG.
    Recept Channels; 1993 Nov 01; 1(1):53-9. PubMed ID: 7521733
    [Abstract] [Full Text] [Related]

  • 50. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines.
    Browning J, Ribolini A.
    J Immunol; 1989 Sep 15; 143(6):1859-67. PubMed ID: 2550545
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
    Luo W, Sharif TR, Houghton PJ, Sharif M.
    Cell Growth Differ; 1997 Nov 15; 8(11):1225-40. PubMed ID: 9372245
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Interleukin-1 alpha and tumor necrosis factor-alpha differentially regulate enkephalin, vasoactive intestinal polypeptide, neurotensin, and substance P biosynthesis in chromaffin cells.
    Eskay RL, Eiden LE.
    Endocrinology; 1992 Apr 15; 130(4):2252-8. PubMed ID: 1372239
    [Abstract] [Full Text] [Related]

  • 55. 125I-BH[Sar9, Met(O2)11]-SP, a new selective ligand for the NK-1 receptor in the central nervous system.
    Tousignant C, Guillemette G, Drapeau G, Télémaque S, Dion S, Regoli D.
    Brain Res; 1990 Aug 06; 524(2):263-70. PubMed ID: 1705465
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Effects of IL-1 and cortisol on beta-adrenergic receptors, cell proliferation, and differentiation in cultured human A549 lung tumor cells.
    Nakane T, Szentendrei T, Stern L, Virmani M, Seely J, Kunos G.
    J Immunol; 1990 Jul 01; 145(1):260-6. PubMed ID: 2162889
    [Abstract] [Full Text] [Related]

  • 59. Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists.
    Fan TP, Hu DE, Guard S, Gresham GA, Watling KJ.
    Br J Pharmacol; 1993 Sep 01; 110(1):43-9. PubMed ID: 7693287
    [Abstract] [Full Text] [Related]

  • 60. Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factor-alpha, interleukin-1 beta and cholecystokinin-8: the possible role of NGF in the inflammatory response.
    Manni L, Lundeberg T, Fiorito S, Bonini S, Vigneti E, Aloe L.
    Clin Exp Rheumatol; 2003 Sep 01; 21(5):617-24. PubMed ID: 14611111
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.